Isolation of human sequences that replicate autonomously in human cells Mol Cell Biol 1989 9: 1026 1026

Safety-modified episomal vectors for human gene therapy Proc Natl Acad Sci USA 1997 94: 6450 6450 Construction of a novel bovine papillomavirus vector without detectable transforming activity suitable for gene transfer Hum Gene Ther 1995 6: 325 325Ĭooper M.J.

A BK virus episomal vector for constitutive high expression of exogenous cDNAs in human cells Arch Virol 1995 140: 335 335 A novel BK virus-based episomal vector for expression of foreign genes in mammalian cells Nucleic Acids Res 1991 19: 1925 1925 Stable replication of plasmids derived from Epstein–Barr virus in various mammalian cells Nature 1985 313: 812 812ĭe Benedetti A., Rhoads R.E. Enhanced expression of recombinant dystrophin following intramuscular injection of Epstein–Barr virus (EBV)-based mini-chromosome vectors in mdx mice Gene Therapy 1999 6: 1331 1331 Sustained transgene expression in vitro and in vivo using an Epstein–Barr virus replicon vector system combined with HVJ liposomes Gene Therapy 1998 5: 1031 1031 Saeki Y., Wataya-Kaneda M., Tanaka K., Kaneda Y. Efficient gene transduction by Epstein–Barr virus-based vectors coupled with cationic liposome and HVJ-liposom Biochem Biophys Res Commun 1997 238: 795 795 Human artificial episomal chromosomes for cloning large DNA fragments in human cells Nat Genet 1994 8: 33 33 Epstein–Barr virus vectors for gene expression and transfer Curr Opin Biotechnol 1998 9: 476 476

Our data suggest that LCRs can contribute to this vital function. Therefore, appropriate control elements to provide and maintain tissue-specific gene expression, as well as the episomal status of REVs is a crucial feature in vector design.

Importantly, our results demonstrate that as in the case of integrated transgenes, expression from within REVs is prone to silencing but that the inclusion of the βLCR prevented this repression of gene function. This demonstrates for the first time the feasibility of using REVs for gene therapy of the haemoglobinopathies. Furthermore, a 38-kb βLCR minilocus-REV cosmid vector was efficiently retained and maintained therapeutic levels of β-globin transgene expression in the absence of drug selective pressure over a 2-month period of continuous culture equivalent to at least 60 generations. Using the human β-globin LCR (βLCR) as a model, we show that this class of control element can drive high levels of tissue-specific gene expression in stably transfected cultured cells from within an Epstein–Barr virus-based plasmid REV. Locus control regions (LCRs) are transcriptional regulatory elements, which possess a dominant chromatin remodelling and transcriptional activating capability conferring full physiological levels of expression on a gene linked in cis, when integrated into the host cell genome.

Difference between plasmid and cosmid